| 摘要 |
Methods of characterizing the degradation of type II collagen in body fluids are disclosed. In a specific method, a sample of body fluid is subjected to at least two distinct immunological assays, each using a different immunological binding partner, and a numerical index is formed representing the difference in the results of the assays. |
